Nestec S.a.

Francois Morgan

Norbert Sprenger

Rafael Berrocal

Marcel Braun

Christine Cherbut

Peter Duncan

This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group consisting of Ga1NAc&#x3b1;1-3Ga1&#x3b2;1-4G1c, Ga1&#x3b2;1-6Ga1Nac&#x3b1;1-3Ga1&#x3b2;1-4G1c and combinations thereof, 20-95 wt % of at least one neutral oligosaccharide selected from the group consisting of Gal&#x3b2;1-6Gal, Gal&#x3b2;1-6Gal&#x3b2;1-4Glc, Gal&#x3b2;1-6Gal&#x3b2;1-6Glc, Gal&#x3b2;1-3Gal&#x3b2;1-3Glc, Gal&#x3b2;1-3Gal&#x3b2;1-4Glc, Gal&#x3b2;1-6Gal&#x3b2;1-6Gal&#x3b2;1-4Glc, Gal&#x3b2;1-6Gal&#x3b2;1-3Gal&#x3b2;1-4Glc, Gal&#x3b2;1-3Gal&#x3b2;1-6Gal&#x3b2;1-4Glc, Gal&#x3b2;1-3Gal&#x3b2;1-3Gal&#x3b2;1-4Glc and combinations thereof and 2-50 wt % of at least one sialylated oligosaccharide selected from the group consisting of NeuAc&#x3b1;2-3Gal&#x3b2;1-4Glc, NeuAc&#x3b1;2-6Ga1&#x3b2;1-4G1c and combinations thereof. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.

Synbiotic mixture

This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group comprising Ga1NAc&#x3b1;1,3Ga1&#x3b2;1,4G1c and Ga1&#x3b2;1,6Ga1NAc&#x3b1;1,3Ga1&#x3b2;1,4G1c, 20-95 wt % of at least one neutral oligosaccharide selected from the group comprising Ga1&#x3b2;1,6Ga1, Ga1&#x3b2;1,6Ga1&#x3b2;1,4G1c Ga1&#x3b2;1,6Ga1&#x3b2;1,6G1c, Ga1&#x3b2;1,3Ga1&#x3b2;1,3G1c, Ga1&#x3b2;1,3Ga1&#x3b2;1,4G1c, Ga1&#x3b2; 1,6Ga1&#x3b2; 1,6Ga1&#x3b2; 1,4GIc, Ga1&#x3b2; 1,6Ga1&#x3b2; 1,3Ga1&#x3b2; 1,4GIc Ga1&#x3b2; 1,3Ga1&#x3b2; 1,6Ga1&#x3b2; 1,4GIc and Ga1&#x3b2;1,3Ga1&#x3b2;1,3Ga1&#x3b2;1,4G1c and 2-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAc&#x3b1;2,3Ga1&#x3b2;1,4G1c and NeuAc&#x3b1;2,6Ga1&#x3b2;1,4G1c. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.

An oligosaccharide mixture derived from animal milk, food products comprising said oligosaccharide mixture and a process for producing said oligosaccharide mixture.

Oligosaccharide mixture

An oligosaccharide mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group comprising GalN Ac&#x3b1;1,3Gal&#x3b2;1,4Glc and Gal&#x3b2;1,6GalN Ac&#x3b1;1,3Gal&#x3b2;1,4Glc, 20-90 wt % of at least one neutral oligosaccharide selected from the group comprising Gal&#x3b2;1,6Gal, Gal&#x3b2;1,6Gl&#x3b2;1,4Glc Gal&#x3b2;1,6Gal&#x3b2;1,6Glc, Gal&#x3b2;1,Gal&#x3b2;1,3Glc, Gal&#x3b2;1,3Gal&#x3b2;1,4Glc, Gal&#x3b2;1,6Gal&#x3b2;1,6Gal&#x3b2;1,4Glc, Gal&#x3b2;1,6Gal&#x3b2;1,3Gal&#x3b2;1,4Glc, Gal&#x3b2;1,3Gal&#x3b2;1,6Gal&#x3b2;1,4Glc and Gal&#x3b2;1,3Gal&#x3b2;1,3Gal&#x3b2;1,4Glc and 5-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAc&#x3b1;2,3Gal&#x3b2;1,4Glc and NeuAc&#x3b1;2,6Gal&#x3b2;1,4Glc; food products comprising said oligosaccharide mixture.

Growing community of inventors

Rennes, France

Francois Morgan